Fortress Biotech

Company snapshot

Fortress Biotech is a biotech organization headquartered in BAY HARBOR ISLANDS, FL, USA. It trades on NYSE under ticker FBIO. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 1 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• 1 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Fortress Biotech. Not investment advice.

• approval Jun 2, 2026

  Big Pharma's Shift to Smaller Deals Boosts Biotech Sector

Recent activity

Latest pipeline, patent, and corporate events for Fortress Biotech.

1. Jul 5, 2022 Patent grant

   Cyproterone acetate compositions and uses thereof

View all clinical trial activity →

• What is Fortress Biotech?

  Fortress Biotech is a biotech organization headquartered in BAY HARBOR ISLANDS, FL, USA. It trades on NYSE under ticker FBIO. NovaPharmaNews links 0 clinical program(s), 0 drug profile(s), and 1 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO s

• Is Fortress Biotech publicly traded?

  Yes. Fortress Biotech is listed with ticker FBIO on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Fortress Biotech develop or market?

  No drug profiles are currently linked to Fortress Biotech. Pipeline programs may still list investigational assets.

• What are the latest developments for Fortress Biotech?

  Browse related news and pipeline sections on this page for coverage and ClinicalTrials.gov-linked program updates.

• What therapeutic areas does Fortress Biotech focus on?

  No specific therapeutic focus areas are currently identified for Fortress Biotech in our database.